Hypoxia in breast cancer: Role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion

Advances in Experimental Medicine and Biology

Volumn 566, Issue , 2005, Pages 333-342

  Vaupel, Peter ^a   Mayer, Arnulf ^a   Briest, Susanne ^a   Höckel, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD FLOW; BREAST CANCER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; GENE EXPRESSION; GENOMICS; GEOMETRY; HUMAN; HYPOXEMIA; IONIZING RADIATION; MICROVASCULATURE; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; OXYGEN TRANSPORT; PERFUSION PRESSURE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEOMICS; SOLID TUMOR; VASCULARIZATION;

ANEMIA; ANOXIA; BREAST NEOPLASMS; DIFFUSION; FEMALE; HUMANS; LYMPHATIC VESSELS; MICROCIRCULATION; MODELS, BIOLOGICAL; OXYGEN; REGIONAL BLOOD FLOW;

EID: 33646887011     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-26206-7_44     Document Type: Conference Paper

References (50)

1. 2 tension measurements, Cancer Res. 51, 3316-3322 (1991).
2. P. Vaupel, S. Briest, and M. Höckel, Hypoxia in breast cancer: Pathogenesis, characterization and biological/therapeutic implications, Wien. Med. Wschr. 152, 334-342 (2002).
3. 2 tension measurements, Cancer Res. 51, 6098-6102 (1991).
4. A. W. Fyles, M. Milosevic, R. Wong, M.-C. Kavanagh, M. Pintilie, A. Sun, W. Chapman, W. Levin, L. Manchul, T. J. Keane, and R. P. Hill, Oxygenation predicts radiation response and survival in patients with cervix cancer, Radiother. Oncol. 48, 149-156 (1998).
5. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix, Radiother. Oncol. 53, 99-104 (1999).
6. M. Nordsmark, and J. Overgaard, A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy, Radiother. Oncol. 57, 39-43 (2000).
7. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher, and M. W. Dewhirst, Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck, Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997).
8. B. Movsas, J. D. Chapman, E. M. Horwitz, W. H. Pinover, R. E. Greenberg, A. L. Hanlon, R. Iyer, and G. E. Hanks, Hypoxic regions exist in human prostate carcinoma, Urology 53, 11-18 (1999).
9. A. C. Koong, V. K. Mehta, Q. T. Le, G. A. Fisher, D. J. Terris, J. M. Brown, A. J. Bastidas, and M. Vierra, Pancreatic tumors show high levels of hypoxia, Int. J. Radiat. Oncol. Biol. Phys. 48, 919-922 (2000).
10. 2 distribution and bioreductive enzymes in human malignant brain tumors, Int. J. Radiat. Oncol. Biol. Phys. 29, 427-432 (1994).
11. D. R. Collingridge, J. M. Piepmeier, S. Rockwell, and J. P. S. Knisely, Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue, Radiother. Oncol. 53, 127-131 (1999).
12. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz, and M. W. Dewhirst, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma, Cancer Res. 56, 941-943 (1996).
13. 31P magnetic resonance spectroscopy in human soft tissue tumours, Acta Oncol. 36, 565-571 (1997).
14. E. Lartigau, H. Randrianarivelo, M.-F. Avril, A. Margulis, A. Spatz, F. Eschwege, and M. Guichard, Intratumoral oxygen tension in metastatic melanoma, Melanoma Res. 7, 400-406 (1997).
15. P. Vaupel, O. Thews, and M. Höckel, Treatment resistance of solid tumors: Role of hypoxia and anemia, Med. Oncol. 18, 243-259 (2001).
16. P. Vaupel, and M. Höckel, Tumor hypoxia and therapeutic resistance, in: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology, edited by M. R. Nowrousian (Springer, Berlin, Heidelberg, New York, 2002), pp. 127-146.
17. M. Höckel, and P. Vaupel, Tumor hypoxia: Definitions and current clinical, biologic and molecular aspects, J. Natl. Cancer Inst. 93, 266-276 (2001).
18. G. L. Semenza, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer 3, 721-732 (2003).
19. G. L. Semenza, HIF-1 and tumor progression: pathophysiology and therapeutics, Trends Mol. Med. 8, S62-S67 (2002).
20. A. L. Harris, Hypoxia - a key regulatory factor in tumour growth, Nat. Rev. Cancer 2, 38-47 (2002).
21. P. Vaupel, A. Mayer, and M. Höckel, Tumor hypoxia and malignant progression, Methods Enzymol. 383, 335-354 (2004).
22. T. I. Goonewardene, H. M. Sowter, and A. L. Harris, Hypoxia-induced pathways in breast cancer, Microsc. Res. Tech. 59, 41-48 (2002).
23. S. M. Evans, and C. J. Koch, Prognostic significance of tumor oxygenation in humans, Cancer Letters 195, 1-16 (2003).
24. G. Gasparini, Prognostic value of vascular endothelial growth factor in breast cancer, Oncologist 5, 37-44 (2000).
25. M. Schindl, S. F. Schoppmann, H. Samonigg, H. Hausmaninger, W. Kwasny, M. Gnant, R. Jakesz, E. Kubista, P. Birner, and G. Oberhuber, Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer, Clin. Cancer Res. 8, 1831-1837 (2002).
26. P. N. Span, J. Bussink, P. Manders, L. V. A. M. Beex, and C. G. J. Sweep, Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome, Br. J. Cancer 89, 271-276 (2003).
27. S. K. Chia, C. C. Wykoff, P. H. Watson, C. Han, R. D. Leek, J. Pastorek, K. C. Gatter, P. Ratcliffe, and A. L. Harris, Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma, J. Clin. Oncol. 19, 3660-3668 (2001).
28. R. Bos, P. v. d. Groep, A. E. Greijer, A. Shvarts, S. Meijer, H. M. Pinedo, G. L. Semenza, P. J. v. Diest, and E. v. d. Wall, Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma, Cancer 97, 1573-1581 (2003).
29. L. Tomes, E. Emberley, Y. Niu, S. Troup, J. Pastorek, K. Strange, A. Harris, and P. H. Watson, Necrosis and hypoxia in invasive breast carcinoma, Breast Cancer Res. Treat. 81, 61-69 (2003).
30. M. Younes, R. W. Brown, D. R. Mody, L. Fernandez, and R. Laucirica, GLUT 1 expression in human breast carcinoma: correlation with known prognostic markers, Anticancer Res. 15, 2895-2898 (1995).
31. P. Vaupel, O. Thews, and M. Höckel, Tumor oxygenation: Characterization and clinical implications, in: rhErythropoietin in Cancer Supportive Treatment, edited by J. F. Smyth, M. A. Boogaerts, and B. R.-M. Ehmer (Marcel Dekker, New York, 1996), pp. 205-239.
32. P. Vaupel, F. Kallinowski, and P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review, Cancer Res. 49, 6449-6465 (1989).
33. P. W. Vaupel, Blood flow, oxygenation, tissue pH distribution, and bioenergetic status of tumors. Lecture 23, Berlin: Ernst Schering Research Foundation (1994).
34. P. Vaupel, and M. Höckel, Durchblutung, Oxygenierungsstatus und metabolisches Mikromilieu des Mammakarzinoms. Pathomechanismen, Charakterisierung und biologische/therapeutische Relevanz, in: Diagnostik und Therapie des Mammakarzinoms - State of the Art, edited by M. Untch, H. Sittek, I. Bauerfeind, G. Konecny, M. Reiser, H. Hepp (Zuckschwerdt, München, 2002), pp. 289-307.
35. R. P. Beaney, Positron emission tomography in the study of human tumors, Semin. Nucl. Med. 14, 324-341 (1984).
36. R. P. Beaney, A. A. Lammertsma, T. Jones, C. G. McKenzie, and K. E. Halnan, Positron emission tomography for in-vivo measurements of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma, Lancet 1(8369), 131-134 (1984).
37. R. Johnson, A thermodynamic method for investigation of radiation induced changes in the microcirculation of human tumors, Int. J. Radiat. Oncol. Biol. Phys. 1, 659-670 (1976).
38. C. B. J. H. Wilson, A. A. Lammertsma, C. G. McKenzie, K. Sikora, and T. Jones, Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: A rapid and noninvasive dynamic method, Cancer Res. 52, 1592-1597 (1992).
39. E. M. Grischke, M. Kaufmann, M. Eberlein-Gonska, T. Mattfeld, Ch. Sohn, and G. Bastert, Angiogenesis as a diagnostic factor in primary breast cancer: Microvessel quantitation by stereological methods and correlation with color Doppler sonography, Onkologie 17, 35-42 (1994).
40. P. Vaupel, Vascularization, blood flow, oxygenation, tissue pH, and bioenergetic status of human breast cancer, Adv. Exp. Med. Biol. 411, 243-254 (1997).
41. P. Vaupel, and M. Höckel, Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance, Int. J. Oncol. 17, 869-879 (2000).
42. C. Peters-Engl, M. Medl, M. Mirau, C. Wanner, S. Bilgi, P. Sevelda, and A. Obermair, Color-coded and spectral Doppler flow in breast carcinomas - Relationship with the tumor microvasculature, Breast Cancer Res. Treat. 47, 83-89 (1998).
43. C. Peters-Engl, W. Frank, S. Leodolter, and M. Medl, Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival, Breast Cancer Res. Treat. 54, 65-71 (1999).
44. P. Vaupel, Oxygenation of human tumors. Strahlenther. Onkol. 166, 377-386 (1990).
45. P. Vaupel, A. Mayer, S. Briest, and M. Höckel, Oxygenation gain factor: A novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers, Cancer Res. 63, 7634-7637 (2003).
46. A. Becker, P. Stadler, R. S. Lavey, G. Hänsgen, T. Kuhnt, C. Lautenschläger, H. J. Feldmann, M. Molls, and J. Dunst, Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas, Int. J. Radiat. Oncol. Biol. Phys. 46, 459-466 (2000).
47. 2 extraction is a key parameter determining the oxygenation status of malignant tumors and normal tissues, Int. J. Oncol. 22, 795-798 (2003).
48. P. Vaupel, D. K. Kelleher, and M. Höckel, Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy, Semin. Oncol. 28, 29-35 (2001).
49. D. P. Bottaro, and L. A. Liotta, Out of air is not out of action, Nature 423, 593-595 (2003).
50. M. Höckel, K. Schlenger, B. Aral, M. Mitze, U. Schäffer, and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56, 4509-4515 (1996).